Effects of Secukinumab on Cardio-metabolic Risk Proteomic profile in Patients with Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: The PROSEC Study
Authors
González-Cantero Á, Barbarroja N, Llamas-Velasco M, de Aragón CAJ, Clemens A, et al.
Journal
Journal of the American Academy of Dermatology 95(1), AB178
Effects of Secukinumab on Cardio-metabolic Risk Proteomic profile in Patients with Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: The PROSEC Study - Publication by Dr. Andreas Clemens | Dr. Andreas Clemens